Following Chemistry professor Charles M. Lieber’s conviction last month, Harvard scientists say they are “shocked” and “saddened” about the prolific research chemist's fall from grace — and apprehensive about the future of international scientific collaboration.
Harvard professor Charles M. Lieber was found guilty of lying to government authorities about his ties to China in federal court on Tuesday, concluding a stunning downfall for one of the country’s top chemists.
Federal officials testified in court Monday that alleged false statements made by Harvard professor Charles M. Lieber prevented government authorities from fully exploring his ties to China.
Sciences Dean Stubbs Says Federal Science Funding Could Increase, Denies ‘Academic Espionage’ at Harvard
Dean of Science Christopher W. Stubbs said in an interview that funding for scientific research has the potential to increase under the Biden administration. Stubbs also objected to the notion that there is “academic espionage” on Harvard’s campus.
U.S. Attorney in Lieber Case Says He Encourages Lawful Academic Collaboration with China: ‘No One is Saying Don’t Do It’
Disclosure by academics and cooperation from universities are paramount in maintaining a balance between open academic exchange and national security priorities, United States Attorney Andrew E. Lelling said in a Jan. 20 interview with The Crimson.
As Joe Biden is inaugurated as the 46th U.S. president Wednesday, a team of Crimson reporters explored how the Biden administration will affect international students, admissions, labor, and everything in between at Harvard. Here's a look at how the Biden administration will reshape the University — and what role Harvard will play in shaping it.
Former Harvard-Affiliated Researcher Ordered to Leave Country for Lying about Research Vials He Took from Lab
Zaosong Zheng, a former researcher at Harvard-affiliated Beth Israel Deaconess Medical Center, was sentenced on Wednesday for lying to federal agents in connection with his attempt to take cancer research to China.
Former Harvard Chemistry department chair Charles M. Lieber pleaded not guilty Tuesday to charges that he lied to federal investigators about research funding he received from China.
Former Chemistry Chair Lieber Indicted by Federal Grand Jury for Making False Statements Regarding Relations to China
A federal grand jury indicted former Harvard chemistry chair Charles M. Lieber on two counts for making false statements to federal investigators who were examining funding he received from the Chinese government, the Department of Justice announced Tuesday.
Harvard Settles Federal Grant Overcharge Allegations for $1.3 Million; University And Professor Deny Wrongdoing
Harvard settled with the federal government for $1.3 million over allegations that a professor at its School of Public Health overcharged federal grants, according to a Monday press release from the Department of Justice.
Senator Marco Rubio Urges Small Business Administration to Re-Examine Grant Policies in Wake of Lieber Arrest
In the wake of Harvard Chemistry department chair Charles M. Lieber’s arrest, United States Senator Marco Rubio (R-Fla.) urged the U.S. Small Business Association in February to ensure recipients of its grant programs do not have connections to governments such as China.
In the wake of federal charges brought against Chemistry department chair Charles M. Lieber for failing to disclose funding from a Chinese university, University President Lawrence S. Bacow said in an interview Monday that Harvard relies upon the “honesty and good faith” of its faculty to disclose external funding.
Lieber’s arrest marked merely the latest development in an ongoing crackdown by the United States government and American universities on “academic espionage,” the process by which scientists pass academic research at American universities to foreign governments.
Current Policy, Past Investigations Offer Window Into Harvard’s Next Steps In Abramson Plagiarism Case
The allegations against Abramson evoke comparisons between University policies for responding to undergraduates who commit academic dishonesty and procedures concerning faculty misconduct.
At least one high-profile paper authored by a former Medical School professor has been formally retracted and a federally funded clinical trial put on hold.
The professor, Piero Anversa, left the Medical School in December 2015 after investigations into the integrity of his research.